Stemmatters is a pre-clinical stage regenerative medicine company developing game changing medical devices for large unmet medical needs. Biomaterial research and development at Stemmatters centres on unique proprietary product development platforms, which offer excellent scope for tailoring biological and physicochemical properties for breakthrough therapeutic applications in regenerative medicin
e. Company premises comprise clean rooms compliant for processing of human tissues and cells (2004/23/EC Directive). In addition, the company operates 300 m2 of BSL Level 2, R&D and QC laboratories for development of medical devices and tissue engineering products. Stemmatters has implemented a QMS compliant with GLP, GMP and ISO 9001:2008 (Certification under progress).